Clinical Research Directory
Browse clinical research sites, groups, and studies.
RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)
Sponsor: University of Southern California
Summary
The objective of this study is to evaluate the effectiveness of trazodone as compared to quetiapine and placebo, in the management of ICU delirium in adult (\>=18 years old) surgical ICU patients. The investigators will compare outcomes such as delirium incidence and duration, in-hospital mortality, 28-day mortality, hospital length of stay (LOS), ICU LOS, mechanical ventilator days, complications, adverse effects, rescue medication use, delirium symptom severity, sleep duration, and sleep quality among participants receiving trazodone, quetiapine, or placebo. The investigators hypothesize participants receiving trazodone will have a shorter duration of delirium, decreased delirium severity, and improved sleep quality compared to participants receiving quetiapine and placebo.
Official title: Comparison of Trazodone vs Quetiapine vs Placebo for the Treatment of ICU Delirium: A Randomized Controlled Trial (The TraQ Study)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-03-01
Completion Date
2026-12-01
Last Updated
2024-05-08
Healthy Volunteers
No
Interventions
Trazodone
Trazodone will be administered to ICU patients who need pharmacological intervention for delirium, if they are randomized to the trazodone arm.
Quetiapine
Quetiapine will be administered to ICU patients who need pharmacological intervention for delirium, if they are randomized to the quetiapine arm.
Placebo
Placebo will be administered to ICU patients who need pharmacological intervention for delirium, if they are randomized to the placebo arm.
Locations (1)
Keck Hospital of the University of Southern California
Los Angeles, California, United States